58411-657Level 3
SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER (TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE)
**Product type:** Human Otc Drug
**Active ingredient:** ENSULIZOLE; OCTINOXATE; TITANIUM DIOXIDE
**Strength:** .428; 1.71; 1.77 g/40mL; g/40mL; g/40mL
**Dosage form:** Emulsion
**Route:** Topical
**Labeler:** SHISEIDO AMERICAS CORPORATION
**Marketing category:** OTC MONOGRAPH DRUG (M020)
GET
/api/v1/systems/ndc_fda/nodes/58411-657Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.